Cargando…
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
In the last few years, immunotherapy has transformed the way we treat solid tumors, including melanoma, lung, head neck, breast, renal, and bladder cancers. Durable responses and long-term survival benefit has been experienced by many cancer patients, with favorable toxicity profiles of immunotherap...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778545/ https://www.ncbi.nlm.nih.gov/pubmed/31410780 http://dx.doi.org/10.1007/s12325-019-01051-z |